GLP-1 AND GIP DUAL AGONISTS SHOW PROMISE GLP-1 and GIP dual agonists offer additional hepatic benefits by activating GIP receptors on adipocytes, promoting healthy adipose tissue expansion, increasing dietary lipid storage, and preventing lipid spillover to the liver
Marchese A, Paing MM, Temple BR, Trejo J
Clinical studies have shown an average weight reduction of 14.9% of initial body weight over 68 weeks
Liu PS, Wang H, Li X, Chao T, Teav T, Christen S, et al
Aggregation and Stability Monitoring Semaglutide may form aggregates or higher-order molecular associations under stress conditions such as temperature fluctuations, agitation, or long-term storage
The compound essentially works on multiple fronts of appetite regulation and metabolic control at once